A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel

Completed · Phase 2 · Has a placebo group

Conditions studied: Acute Ischemic Stroke, Transient Ischemic Attack (TIA)

In brief

The purpose of this clinical study is to determine whether the addition of an oral Factor XIa Inhibitor to Aspirin and Clopidogrel is more effective than standard therapy in secondary stroke prevention.

Key facts

Study ID
NCT03766581
Run by
Bristol-Myers Squibb
People needed
2366
Starts
2019-01-27
Expected to finish
2022-03-31
Last updated by the study team
2023-06-12

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.